- Biomarker of Disease
- Biomarker of Exposure
Biomarkers Market size was valued at USD 45.1 billion in 2022 and is poised to grow at a significant CAGR of 12.2% from 2023-2029. Biomarkers are cellular or molecular diagnostic tools, measured in in biological samples, for instance, urine, stool and blood. It is utilized as an indicator to check and assess biological, pharmacological and pathogenic procedures. Biomarkers range from proteins, lipids, carbohydrates, RNA, DNA, hormones, platelets etc. Currently wide range of biomarkers market are available for the different systems such as cardiovascular, metabolic system and immune system. Biomarkers not only help in diagnosis of the disease but also helps in tracking progression, regression and outcome after the intervention. Furthermore, biomarkers are also used in the drug development. Biomarkers of exposure and biomarkers of disease are the two major types of diagnostic biomarkers. Biomarkers of exposure are a new method for determining the quantity of harmful chemicals in a person's body. These biomarkers allow for the detection of aberrant activity and the calculation of the pre-disease state. Biomarkers of disease are used to identify disease conditions and to help validate clinical trials for new drugs. A perfect biomarker has specific qualities, such as being safe and easy to assess, being cost-effective to follow up on, and being changeable with treatment that is consistent across gender and ethnic groups. Biomarkers are used to predict serious illnesses like diabetes and cardiovascular disease, as well as cancer, neurological disorders, immunological disorders, and others. Every biomarker shows if a disease or a state of health exists, and they can be combined to give a complete picture of how healthy a person is and whether a diagnosis is required. Biomarkers are also employed in imaging technologies to give clear imaging of cancer tumours and other issues, as well as in clinical trials to identify the effect and effects of medications early on.
Biomarkers Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
12.2%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Biomarkers Market Dynamics
biomarkers market primarily driven by rise in demand and need for the accurate diagnosis of disease and progression of the intervention due to the increase in diseases like cancer and cardiovascular diseases. In addition, initiatives taken by the government and market players in biomarker research coupled with increase in the number of clinical research organizations are expected to boost the market over the forecast period. Furthermore, expansion of the applications of biomarkers in drug development and diagnostic segments projected to propel the growth of market in near future. On the other hand, high cost of discovery and development, poor reimbursement policies and technical issues in sample collection may hamper the market growth over the forecast period.
North-America Got Significant Share
Biomarkers Market Regional Analysis
Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America projected to have dominated market for biomarkers owing to the increase in ageing population and diagnosis of age related diseases. Asia Pacific projected to have the lucrative opportunity of growth owing to the increase in the cardiovascular diseases and cancer cases. For instance, According to data of Ministry of Health, China, there were 203 million people are suffering from the cardiovascular diseases and is expected to increase 73% by 2030. Furthermore, market players interest in expansion of their companies to Asia Pacific region due to low cost of production. This is likely to positively impact the growth of market in this region. Europe market expected to have the notable growth rate owing to the presence of the key market players and increase in the prevalence of diseases in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
Biomarkers Market Segmentation
By Type
By Application
- Disease Diagnosis
- Disease Progression
- Drug Discovery and Development
- Development of Molecular Diagnostics
- Forensic
- Others
By End User
- Hospitals
- Research Organizations
- Diagnostic Centers
- Others
Frequently Asked Questions
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Biomarkers Market size was valued at USD 45.1 billion in 2022 and is projected to reach USD 98.2 billion by 2029 at a CAGR of 12.2% during the forecast period 2023 to 2029.
One of the threats to the biomarkers market is the potential for regulatory challenges and uncertainties surrounding biomarker validation and approval processes.
| 1.Executive Summary |
| 2.Global Biomarkers Market Introduction |
| 2.1.Global Biomarkers Market - Taxonomy |
| 2.2.Global Biomarkers Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Biomarkers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Biomarkers Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Biomarkers Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Biomarker of Disease |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Biomarker of Exposure |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Biomarkers Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Disease Diagnosis |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Disease Progression |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Drug Discovery and Development |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Development of Molecular Diagnostics |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Forensic |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Biomarkers Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Organizations |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Biomarkers Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Biomarker of Disease |
| 9.1.2.Biomarker of Exposure |
| 9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Disease Diagnosis |
| 9.2.2.Disease Progression |
| 9.2.3.Drug Discovery and Development |
| 9.2.4.Development of Molecular Diagnostics |
| 9.2.5.Forensic |
| 9.2.6.Others |
| 9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Research Organizations |
| 9.3.3.Diagnostic Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Biomarker of Disease |
| 10.1.2.Biomarker of Exposure |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Disease Diagnosis |
| 10.2.2.Disease Progression |
| 10.2.3.Drug Discovery and Development |
| 10.2.4.Development of Molecular Diagnostics |
| 10.2.5.Forensic |
| 10.2.6.Others |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Research Organizations |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Biomarker of Disease |
| 11.1.2.Biomarker of Exposure |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Disease Diagnosis |
| 11.2.2.Disease Progression |
| 11.2.3.Drug Discovery and Development |
| 11.2.4.Development of Molecular Diagnostics |
| 11.2.5.Forensic |
| 11.2.6.Others |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Research Organizations |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Biomarker of Disease |
| 12.1.2.Biomarker of Exposure |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Disease Diagnosis |
| 12.2.2.Disease Progression |
| 12.2.3.Drug Discovery and Development |
| 12.2.4.Development of Molecular Diagnostics |
| 12.2.5.Forensic |
| 12.2.6.Others |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Research Organizations |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Biomarker of Disease |
| 13.1.2.Biomarker of Exposure |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Disease Diagnosis |
| 13.2.2.Disease Progression |
| 13.2.3.Drug Discovery and Development |
| 13.2.4.Development of Molecular Diagnostics |
| 13.2.5.Forensic |
| 13.2.6.Others |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Research Organizations |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.QIAGEN N.V. (Netherlands) |
| 14.2.2.Merck Millipore (U.S.) |
| 14.2.3.PerkinElmer, Inc. (U.S.) |
| 14.2.4.Enzo Biochem, Inc. (U.S.) |
| 14.2.5.Bio-Rad Laboratories, Inc. (U.S.) |
| 14.2.6.Siemens Healthineers (Germany) |
| 14.2.7.Hoffmann-La Roche AG (Switzerland) |
| 14.2.8.Thermo Fisher Scientific, Inc. (U.S.) |
| 14.2.9.Abbott Laboratories (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- QIAGEN N.V. (Netherlands)
- Merck Millipore (U.S.)
- PerkinElmer, Inc. (U.S.)
- Enzo Biochem, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Siemens Healthineers (Germany)
- Hoffmann-La Roche AG (Switzerland)
- Thermo Fisher Scientific, Inc. (U.S.)
- Abbott Laboratories (U.S.)